These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 35325128)

  • 1. The effect of antifungal resistance development on the virulence of Candida species.
    Bohner F; Papp C; Gácser A
    FEMS Yeast Res; 2022 Apr; 22(1):. PubMed ID: 35325128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.
    Jensen RH
    Dan Med J; 2016 Oct; 63(10):. PubMed ID: 27697142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance of Candida to azoles and echinocandins worldwide.
    Pristov KE; Ghannoum MA
    Clin Microbiol Infect; 2019 Jul; 25(7):792-798. PubMed ID: 30965100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in Intensive Care Unit (ICU) and non-ICU settings in the SENTRY Antimicrobial Surveillance Program (2008-2009).
    Pfaller MA; Messer SA; Moet GJ; Jones RN; Castanheira M
    Int J Antimicrob Agents; 2011 Jul; 38(1):65-9. PubMed ID: 21514797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimycotic Drugs and their Mechanisms of Resistance to
    Dahiya S; Sharma N; Punia A; Choudhary P; Gulia P; Parmar VS; Chhillar AK
    Curr Drug Targets; 2022; 23(2):116-125. PubMed ID: 34551694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Review on Molecular Mechanisms of Antifungal Resistance in
    Lotfali E; Fattahi A; Sayyahfar S; Ghasemi R; Rabiei MM; Fathi M; Vakili K; Deravi N; Soheili A; Toreyhi H; Shirvani F
    Microb Drug Resist; 2021 Oct; 27(10):1371-1388. PubMed ID: 33956513
    [No Abstract]   [Full Text] [Related]  

  • 8. Triazole Evolution of Candida parapsilosis Results in Cross-Resistance to Other Antifungal Drugs, Influences Stress Responses, and Alters Virulence in an Antifungal Drug-Dependent Manner.
    Papp C; Bohner F; Kocsis K; Varga M; Szekeres A; Bodai L; Willis JR; Gabaldón T; Tóth R; Nosanchuk JD; Vágvölgyi C; Gácser A
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33115837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elucidating drug resistance in human fungal pathogens.
    Xie JL; Polvi EJ; Shekhar-Guturja T; Cowen LE
    Future Microbiol; 2014; 9(4):523-42. PubMed ID: 24810351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A chemical screen identifies structurally diverse metal chelators with activity against the fungal pathogen
    Fallah S; Duncan D; Reichl KD; Smith MJ; Wang W; Porco JA; Brown LE; Whitesell L; Robbins N; Cowen LE
    Microbiol Spectr; 2024 Apr; 12(4):e0409523. PubMed ID: 38376363
    [No Abstract]   [Full Text] [Related]  

  • 11. Monitoring Antifungal Resistance in a Global Collection of Invasive Yeasts and Molds: Application of CLSI Epidemiological Cutoff Values and Whole-Genome Sequencing Analysis for Detection of Azole Resistance in Candida albicans.
    Castanheira M; Deshpande LM; Davis AP; Rhomberg PR; Pfaller MA
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28784671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between antifungal consumption and the distribution of Candida species in different hospital departments of a Lebanese medical Centre.
    Awad L; Tamim H; Abdallah D; Salameh M; Mugharbil A; Jisr T; Zahran K; Droubi N; Ibrahim A; Moghnieh R
    BMC Infect Dis; 2018 Nov; 18(1):589. PubMed ID: 30453891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tipping the balance both ways: drug resistance and virulence in Candida glabrata.
    Vale-Silva LA; Sanglard D
    FEMS Yeast Res; 2015 Jun; 15(4):fov025. PubMed ID: 25979690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of global antifungal surveillance results reveals predominance of Erg11 Y132F alteration among azole-resistant Candida parapsilosis and Candida tropicalis and country-specific isolate dissemination.
    Castanheira M; Deshpande LM; Messer SA; Rhomberg PR; Pfaller MA
    Int J Antimicrob Agents; 2020 Jan; 55(1):105799. PubMed ID: 31520783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifungal Combinations against
    Fioriti S; Brescini L; Pallotta F; Canovari B; Morroni G; Barchiesi F
    J Fungi (Basel); 2022 Oct; 8(10):. PubMed ID: 36294642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro resistance of Candida species to antifungal agents].
    Banach-Piatkowska W; Kotłowski A; Humanowska J; Mayer L; Kowalczyk D
    Wiad Parazytol; 2001; 47(4):811-6. PubMed ID: 16886432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
    Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
    J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commonly Used Oncology Drugs Decrease Antifungal Effectiveness against Candida and Aspergillus Species.
    Butts A; Reitler P; Ge W; Fortwendel JR; Palmer GE
    Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of C-5 Sterol Desaturase Activity Results in Increased Resistance to Azole and Echinocandin Antifungals in a Clinical Isolate of Candida parapsilosis.
    Rybak JM; Dickens CM; Parker JE; Caudle KE; Manigaba K; Whaley SG; Nishimoto AT; Luna-Tapia A; Roy S; Zhang Q; Barker KS; Palmer GE; Sutter TR; Homayouni R; Wiederhold NP; Kelly SL; Rogers PD
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA; Rhomberg PR; Messer SA; Jones RN; Castanheira M
    Diagn Microbiol Infect Dis; 2015 Aug; 82(4):303-13. PubMed ID: 25986029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.